Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (NDAQ:AGRX)

Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline

GlobeNewswire July 12, 2016

Agile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer

GlobeNewswire July 6, 2016

Agile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference

GlobeNewswire June 23, 2016

Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs

GlobeNewswire June 16, 2016

Agile Therapeutics to Present at the William Blair & Company’s 36th Annual Growth Stock Conference

GlobeNewswire June 7, 2016

Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference

GlobeNewswire June 2, 2016

Agile Therapeutics Reports First Quarter 2016 Financial Results

GlobeNewswire May 9, 2016

Agile Therapeutics to Present at Women's Health 2016: The 24th Annual Congress

GlobeNewswire April 15, 2016

Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference

GlobeNewswire March 30, 2016

Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results

GlobeNewswire March 9, 2016

Agile Therapeutics to Present at the 28th Annual ROTH Conference

GlobeNewswire March 3, 2016

Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors

GlobeNewswire February 24, 2016

Agile Therapeutics to Present at the 2016 RBC Capital Markets' Global Healthcare Conference

GlobeNewswire February 16, 2016

Agile Therapeutics to Present at the 2016 RBC Capital Markets’ Global Healthcare Conference

Press Releases February 16, 2016

Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters

GlobeNewswire February 4, 2016

Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock

GlobeNewswire January 22, 2016

Agile Therapeutics Announces Proposed Offering of Common Stock

GlobeNewswire January 21, 2016

Agile Therapeutics to Present at Noble Financial Capital Markets' Twelfth Annual Equity Conference

GlobeNewswire January 15, 2016

Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey's Technology Business Tax Certificate Transfer Program

GlobeNewswire December 1, 2015

Technical Data and the Price Movement - Research on Farmers Capital Bank, Veracyte, Townsquare Media, and Agile Therapeutics

Accesswire November 30, 2015